tiakis Biotech AG
PrivateLast Round
Series A
Oct 15, 2021
Company Overview
tiakis Biotech AG is a biotechnology company that develops anti-inflammatory and tissue-protective therapeutic drugs for pulmonary and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
tiakis Biotech AG Comparables
Compare tiakis Biotech AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cereno Scientific | 79% | |
| GSK plc | 75% | |
| Ono Pharmaceutical Co., Ltd. | 71% |
tiakis Biotech AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 15, 2021 |
tiakis Biotech AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elevat3 Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 308% MoM, reaching 1.6K.
tiakis Biotech AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about tiakis Biotech AG's valuation, stock price, and market status.
Is tiakis Biotech AG a public or private company?
tiakis Biotech AG is a private company.
What is the current stock price of tiakis Biotech AG?
tiakis Biotech AG is a private company with no public stock price. No recent secondary market data is available.
How much is tiakis Biotech AG worth (valuation)?
Valuation information for tiakis Biotech AG is not publicly available.
Can I buy tiakis Biotech AG stock?
tiakis Biotech AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was tiakis Biotech AG's last funding round?
tiakis Biotech AG's most recent funding round was Series A on October 15, 2021.
Who are the main investors in tiakis Biotech AG?
Key investors in tiakis Biotech AG include Elevat3 Capital.
Will tiakis Biotech AG IPO soon?
No public IPO plans have been announced for tiakis Biotech AG.
How can I track tiakis Biotech AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor tiakis Biotech AG's secondary market activity and sign up for updates.